Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).

Source:http://linkedlifedata.com/resource/pubmed/id/21300181

Download in:

View as

General Info

PMID
21300181